CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 13 No. 2
 

Fewer Complications With Modified Radical Surgery of the Vulva

February 1, 1999

Due to the psychosexual consequences and significant morbidity associated with the standard radical vulvectomy procedure, there has been a trend toward vulvar conservation in the management of women with vulvar cancer. The question has been raised as to whether modified radical vulvar surgery (partial removal of the entire vulva) has reduced the complications while preserving the excellent disease-free survival and low recurrence rates seen with the more radical approach.

A study in the October issue of Gynecologic Oncology, conducted by Javier F. Magrina, MD, Mayo Clinic, Scottsdale, Arizona, and colleagues, explored the appropriateness of the more conservative approach.

The researchers conducted a retrospective review of 225 patients with vulvar cancer treated between January 1, 1976, and December 31, 1990. Of the 225 patients, 134 patients had radical surgery; 91 patients had modified radical surgery—65 of whom had vulvar excision alone and the remaining 26 of whom had lymph node removal via a separate groin incision.

Results

The results of both types of surgery in the 225 patients (mean age, 68.2 years) included the following:

  • Cancerous groin recurrences after lymphadenectomy were noted in 4 of 134 patients in the radical vulvar surgery group vs 2 of 26 patients in the modified radical surgery group.

  • Subsequent cancerous groin node growth developed in 5 of the 78 patients, 65 of whom were treated with vulvar excision alone and 13 with additional unilateral lymphadenectomy. By study definition, the latter group had modified radical surgery. Metastasis alone occurred in 6 of 134 patients in the radical surgery group but in none of the modified radical surgery group. Development of both groin and distant metastasis occurred in only three patients treated by the modified radical surgery.

  • Surgical complications were noted in 19 patients (20.9%) in the modified radical group and in 80 patients (59.7%) in the radical group. Vulvar complications occurred in 7 (10.8%) of 65 patients in the vulvar excision group, 3 (11.5%) of 26 patients in the modified radical surgery group, and 49 (36.6%) of 134 patients in the radical surgery group.

Conclusion

The study concluded that modified radical vulvar surgery is associated with decreased complications and improved 5-year overall disease-free rates, as compared with radical vulvar surgery.

“As was done with breast cancer treatment, we are refining our procedures and have determined that a more conservative surgery is best for most women who develop vulvar cancer. Our goal is to cure this disease while still allowing patients to lead happy and healthy lives,” says Karl C. Podratz, president of the Society of Gynecologic Oncologists and director of the Department of Gynecologic Oncology at the Mayo Clinic.

Coauthors of the study include Jeffrey Cornella, Department of Obstetrics and Gynecology, Mayo Clinic, Scottsdale, Arizona; Amy Weaver, Section of Biostatistics, Thomas A. Gaffey, MD, Division of Anatomic Pathology, Maurice J. Webb, MD, and Karl C. Podratz, MD, Section of Gynecologic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota; and Jesus Gonzalez-Bosquet, Hospital vall D’Hebron, Barcelona, Spain.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy